Caris Life Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CAI | TECH | 600645.SS | O15.F | 340450.KQ | DNA | |
|---|---|---|---|---|---|---|
| Market cap | 9.39B | 11.42B | 8.36B | 2.54B | 182.35B | 784.51M |
| P/E (TTM) | 19.7 | 62.7 | 74.4 | — | — | — |
| Forward P/E | 89.3 | 31.5 | 40.6 | — | — | -4.0 |
| Price/book | 16.3 | 5.4 | 2.1 | 5.2 | — | 1.8 |
| Dividend yield | — | 0.44% | — | — | — | — |
| 1-year change | +12.46% | +25.01% | −29.27% | −22.42% | +13.37% | +3.10% |
| Today | +1.13% | +0.10% | +1.94% | 0.00% | −3.26% | +8.27% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All CAI news ›Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Star Local Media Caris Life Sciences Logo Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,00
More from 1 other outlet
Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript
Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call November 4, 2026 4:30 PM EST J. Denton - Senior VP, General Counsel & SecretaryDavid Halbert - Chairman, CEO & FounderBrian Brille - Executive Vice Chairman & Executive VPDavid Spetzler…
More from 1 other outlet
Caris Life Sciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView Caris Life Sciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
One moment, please...
Celanese (NYSE:CE – Get Free Report) had its target price lifted by Citigroup from $58.00 to $65.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the basic materials company’s…
Caris Life Sciences (NASDAQ:CAI) Hits New 1-Year High – Time to Buy?
Posted by Tristan Rich on Oct 27th, 2026 Shares of Caris Life Sciences, Inc. (NASDAQ:CAI – Get Free Report) reached a new 52-week high during trading on Tuesday. The company traded as high as $33.20 and last traded at $33.1890, with a…
Caris Life Sciences, Inc. (CAI) – What Are Brokerages Thinking About This Stock?
Shares of Caris Life Sciences, Inc. (NASDAQ:CAI – Get Free Report) have been given an average recommendation of “Moderate Buy” by the fourteen brokerages that are covering the stock, MarketBeat reports.
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
/PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of the second commercial in a series promoting Caris... New campaign connects AI-powered performance insights linking advanced…
Caris Life Sciences, Inc. (NASDAQ:CAI) Stock Has Average Target Price of $27.82 According to Brokerages
MarketBeat Caris Life Sciences, Inc. (NASDAQ:CAI) Stock Has Average Target Price of $27.82 According to Brokerages - Analysts maintain a moderately bullish view of Caris Life Sciences, with eight
Caris Life Sciences, Inc. $CAI Stake Cut by Salem Investment Counselors Inc.
MarketBeat Caris Life Sciences, Inc. $CAI Stake Cut by Salem Investment Counselors Inc. - Salem Investment Counselors cut its Caris Life Sciences stake by 85% in the third quarter, selling 85,000 shares and retaining 15,000
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
Caris Life Sciences (NASDAQ: CAI) will present eight research posters at the ESMO Congress, taking place October 23–27, 2026, in Madrid, Spain. On Oct 14, the day this news came out, the latest delayed price for CAI is 5.60% above the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com6
- marketbeat.com3
- prnewswire.com3
- seekingalpha.com2
- stocktitan.net2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.